Systematic Reviews (May 2022)
Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review
Abstract
Abstract Trial registration Registered with PROSPERO ( CRD42021267844 ) dated 14.07.2021.
Keywords